Indinavir

Cat. No.: IBDI-434855

Indinavir (MK-639 free base) is an orally active and selective HIV-1 protease inhibitor with a Ki of 0.54 nM for PR. Indinavir exhibits anticancer activity by inhibiting the activation of MMPs-2 hydrolysis, anti-angiogenesis and inducing apoptosis. Indinavir is also a SARS-CoV 3CL pro inhibitor.

Product Details

Target	HIV | HIV | Protease | Apoptosis | MMP | SARS-CoV
Molecular Weight	613.79
Synonyms	MK-639 free base, L-735524 free base
SMILES	O=C([[email protected]@H](C[[email protected]](O)CN(CCN(CC1=CN=CC=C1)C2)[[email protected]@H]2C(NC(C)(C)C)=O)CC3=CC=CC=C3)N[[email protected]]4C(C=CC=C5)=C5C[[email protected]]4O

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.